• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AQUABILITI AMUSA FLUSH SYRINGE; SALINE, VASCULAR ACCESS FLUSH

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AQUABILITI AMUSA FLUSH SYRINGE; SALINE, VASCULAR ACCESS FLUSH Back to Search Results
Model Number 2T0806
Device Problems Nonstandard Device (1420); Device Contaminated During Manufacture or Shipping (2969)
Patient Problem No Patient Involvement (2645)
Event Date 04/07/2015
Event Type  malfunction  
Manufacturer Narrative
Syringe plunger tip manufacturer reported occasionally a small shard of metal from the process can become lodged in the material that is injection molded.They indicated several quality checks exist in their production line to catch any plunger tips that have any metal in them, but admit that it is a possible occurrence.Results of chemical (inorganic) analyses under review.
 
Event Description
Appearance of a growth on the rubber stopper (inside of syringe) and a dark orange-brown saline color.The syringe was not used on a patient and was not removed from its packaging.Upon visual evaluation of the returned syringe it appeared that a small piece of metal was lodged in the plunger tip, which had then corroded with exposure to the saline solution in the syringe thus causing the cloudiness.
 
Manufacturer Narrative
To evaluate any health concerns regarding the cloudiness in the saline solution observed in the reported product, aquabiliti contracted integrated analytical laboratories llc (ial) to conduct inorganic test of the solutions from the cloudy syringe.Aquabiliti also sent a retained sample from lot kh040162 to be likewise tested as a control sample.The conclusion is that the allowable limits, based on mg/kg body weight, demonstrate that all patients and body masses have tolerable intake (ti) levels well above the exposure levels of the inorganic reported in the ial report.Both repeated and long-term use of the reported device, including pediatric and neonate populations, would be considered reasonably safe without significant toxicological concerns.Allowable limits were calculated in accordance with the methods described in ansi/aami/iso 10993-17:2002 biological evaluation of medical devices-part 17: methods for the establishment of allowable limits for leachable substances.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AMUSA FLUSH SYRINGE
Type of Device
SALINE, VASCULAR ACCESS FLUSH
Manufacturer (Section D)
AQUABILITI
5209 linbar dr
ste 640
nashville TN 37211
Manufacturer Contact
john beasley
5209 linbar dr
ste 640
nashville, TN 37211
6158332633
MDR Report Key5783902
MDR Text Key50074027
Report Number1000151124-2016-00001
Device Sequence Number1
Product Code NGT
Combination Product (y/n)N
PMA/PMN Number
K111034
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type other
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 07/05/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/11/2016
Is this a Product Problem Report? Yes
Device Operator Other
Device Expiration Date12/31/2016
Device Model Number2T0806
Device Catalogue Number2T0806
Device Lot NumberKH04162
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? No
Date Manufacturer Received04/07/2015
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured12/21/2014
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-